These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10725863)

  • 1. Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture.
    El Etreby MF; Liang Y; Lewis RW
    Prostate; 2000 Apr; 43(1):31-42. PubMed ID: 10725863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells.
    El Etreby MF; Liang Y; Wrenn RW; Schoenlein PV
    Breast Cancer Res Treat; 1998 Sep; 51(2):149-68. PubMed ID: 9879777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells.
    Liang Y; Eid MA; El Etreby F; Lewis RW; Kumar MV
    Int J Oncol; 2002 Dec; 21(6):1259-67. PubMed ID: 12429976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
    Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
    Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice.
    El Etreby MF; Liang Y; Johnson MH; Lewis RW
    Prostate; 2000 Feb; 42(2):99-106. PubMed ID: 10617866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
    Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
    Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H; Lü JJ; Gao QZ; Zhang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells.
    Sridhar S; Ali AA; Liang Y; El Etreby MF; Lewis RW; Kumar MV
    Cancer Res; 2001 Oct; 61(19):7179-83. PubMed ID: 11585752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim.
    Periyasamy-Thandavan S; Takhar S; Singer A; Dohn MR; Jackson WH; Welborn AE; LeRoith D; Marrero M; Thangaraju M; Huang S; Schoenlein PV
    Breast Cancer Res; 2012 Mar; 14(2):R52. PubMed ID: 22429491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer.
    Schoenlein PV; Hou M; Samaddar JS; Gaddy VT; Thangaraju M; Lewis J; Johnson M; Ganapathy V; Kallab A; Barrett JT
    Int J Oncol; 2007 Sep; 31(3):643-55. PubMed ID: 17671693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endometrial cancer cell lines by mifepristone (RU 486).
    Schneider CC; Gibb RK; Taylor DD; Wan T; Gerçel-Taylor C
    J Soc Gynecol Investig; 1998; 5(6):334-8. PubMed ID: 9824816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
    Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
    Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice.
    El Etreby MF; Liang Y
    Breast Cancer Res Treat; 1998 May; 49(2):109-17. PubMed ID: 9696393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-implantation activity of antiestrogens and mifepristone.
    Dao B; Vanage G; Marshall A; Bardin CW; Koide SS
    Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells.
    Diel P; Smolnikar K; Michna H
    Breast Cancer Res Treat; 1999 Nov; 58(2):87-97. PubMed ID: 10674872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.
    Bardon S; Vignon F; Montcourrier P; Rochefort H
    Cancer Res; 1987 Mar; 47(5):1441-8. PubMed ID: 3815345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Bcl-2 overexpression in human prostate cancer cells in vitro and in vivo.
    Kajiwara T; Takeuchi T; Ueki T; Moriyama N; Ueki K; Kakizoe T; Kawabe K
    Int J Urol; 1999 Oct; 6(10):520-5. PubMed ID: 10533903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells.
    Danforth DN
    J Endocrinol; 2004 Nov; 183(2):395-404. PubMed ID: 15531727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
    Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.